3-CMC gets its own Schedule I listing; it was already Schedule I as an isomer of 4-CMC
The Drug Enforcement Administration has given 3-CMC (3-chloromethcathinone), a synthetic cathinone, its own line and drug code in Schedule I[1]. The rule took effect on publication, November 6, 2026[1].
Nothing about its legal status changed. 3-CMC was already Schedule I[1]. It is a positional isomer of 4-CMC, which is a Schedule I hallucinogen[1]: the two molecules differ only in where the chlorine atom sits on the ring[1]. Schedule I's hallucinogen list covers the positional isomers of each substance on it, so 3-CMC has been Schedule I since 4-CMC was, on December 17, 2025[1]. Every Schedule I rule and criminal penalty has applied to it all along and still does[1].
Why list it separately
The rule follows the UN's 2024 decision to add 3-CMC to Schedule II of the 1971 Convention on Psychotropic Substances[1], CND Decision 67/2[1]. A drug code of its own lets DEA set production quotas for 3-CMC itself and grant quotas to the registered manufacturers that make it[1]. The docket is DEA-1768[1].
Comments
Sign in to join the conversation.
No comments yet.